Cogwear Featured as a Startup to Watch in 2025
Cogwear was listed as one of PHL Inno’s Startups to Watch.
Interius Ranks in Top Ten of Capital Raises by Philadelphia Startups in 2024
Interius was recognized in the Philadelphia Business Journal’s “PHL Inno 2024 in Review” as one of the top Philadelphia-area startups raising capital last year.
Penn Spinout Gemma Therapeutics Raises $34 million to Develop Gene Therapies for Rare Diseases
Gemma Bio raised $34 million in a seed round led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital.
Penn’s Chief Innovation Officer John Swartley Interviewed by BioBuzz @ Philly Builds Bio+ Symposium and nominated for the Life Science Cares Leader of the Year Award
In the interview, Dr. Swartley talks about how he leads and supports innovation initiatives across Penn and his career in technology transfer.
Michael Kahana Featured in NY Post for Memory Research
Michael Kahana was recently featured in the New York Post for his cutting-edge research in memory recall.
Penn Engineering’s Shu Yang to Co-Design Artificial Reef Structures that Help Harness Wave Energy
Dr. Yang’s focus is developing low-cost and recycled carbonated materials that are safe for, and tolerant of, the marine environment.
Jay Z’s Shawn Carter Foundation in Collaboration with Coalition for Equity and Opportunity at Penn’s Wharton School, Launch ‘Champions for Financial Legacy’ Program for HBCUs
This partnership focuses on transforming Dr. Weigelt's community program, "Bridges to Wealth," into a broader initiative called "Champions for Financial Legacy."
Mitchell Lab Discovers Siloxane-Enhanced Nanoparticles and Refines LNPs to Advance mRNA Medicine
A group of researchers at Penn Engineering led by Michael Mitchell, PhD, Associate Professor in Bioengineering, have developed a method to direct lipid nanoparticles (LNPs) to target specific tissues.
Franklin Biolabs Names its First CEO
Franklin Biolabs, a Penn spinout founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, has named Vatsala Naageshwaran as its first chief executive officer.
EpiVario Secures Key Patents for Innovative Addiction Treatment
EpiVario, Inc., a Penn spinout co-founded by Shelley Berger, PhD, the Daniel S. Och University Professor at Penn Medicine, announced the issuance to Penn of US Patent No. 12,077,527.